Abstract:Self-assembled lipid nanoparticles containing Gd-chelating lipids are a new type of positive magnetic resonance imaging contrast agents (MRI CAs). High molecular weight imposes reduced molecular reorientation (τr) and corresponding longer reorientation correlation times (τc), finally resulting in overall high relaxivity (r1) of such contrast agents. Therefore, we report nanoassemblies based on two types of amphiphile molecules: glyceryl monooleate (GMO) as a matrix embedded with DTPA-bis(stearylamide) and its gadolinium salt (DTPA-BSA-Gd) as a Gd-chelating lipid, stabilized by surfactant Pluronic F127 molecules. The loading of DTPA-BSA-Gd into the GMO matrix was investigated at low (5% w/w) and high (30, 40, 50% w/w) contents. Small angle X-ray scattering (SAXS), cryogenic transmission electron microscopy (cryo-TEM) and dynamic light scattering (DLS) results show that although the nanoassembly of both amphiphile molecules within the nanoparticle is disturbed in terms of the formed phases, this composition ensures their colloidal stability. In nanoparticles with low DTPA-BSA-Gd contents, the assembly results in a cubic diamond phase that is co-existing with a fraction of liposomes. For high DTPA-BSA-Gd contents, swelling of the structure occurs such that the initially formed primitive cubic phase transforms toward a lamellar phase in the nanoassemblies. Results from inductively coupled plasma mass spectrometry (ICP-MS) indicate that for almost all systems, the loading efficiency (LE) of DTPA-BSA-Gd is high (reaching up to approx. 85%), and the nanoassembly provides strong entrapment of Gd3+ ions, which are then efficiently uptaken by cells. Moreover, the higher the surfactant content, the higher the LE. The viability studies demonstrate that the prepared nanoassemblies preserve high biocompatibility towards both cancer (HeLa) and normal cells (MSU 1.1). Nuclear magnetic resonance relaxometry studies (NMR relaxometry) followed by MRI on the prepared nanoassembly dispersions proved that the formation of GMO@DTPA-BSA-Gd nanoassemblies, considered as high molecular weight CAs, results in high relaxivity parameters (e.g., r1 = 19.72 mM-1 s-1 for 2GMO-40DTPA-10F127) that are superior to commercially developed ones (e.g., Magnevist or Gadovist). These comprehensive studies imply that a high degree of internal ordering of nanoassemblies with a higher content of Gd-chelating lipid is not a decisive factor in determining the increase in relaxivity, thus confirming their potential as positive MRI CAs.

Facile Synthesis of Weakly Ferromagnetic Organogadolinium Macrochelates-Based T1-Weighted Magnetic Resonance Imaging Contrast Agents

Kilogram scale facile synthesis and systematic characterization of a Gd-macrochelate as T1-weighted magnetic resonance imaging contrast agent

A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox‐sensitive biodegradable macromolecular MRI contrast agent

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Preparation of MRI-visible Gadolinium Methacrylate Nanoparticles with Low Cytotoxicity and High Magnetic Relaxivity

Exceedingly Small Gadolinium Oxide Nanoparticles with Remarkable Relaxivities for Magnetic Resonance Imaging of Tumors

Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent

Gadolinium(III) Complex-Backboned Branched Polymers As Imaging Probes for Contrast-Enhanced Magnetic Resonance Angiography

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Reductive Microenvironment Responsive Gadolinium-Based Polymers As Potential Safe MRI Contrast Agents

Linear and Core-Crosslinked Glycopolymer-Gadolinium Conjugates: Preparation and Their Behaviors as Nanoscale Magnetic Resonance Imaging Contrast Agents.

Gadolinium-Incorporated Carbon Nanodots for T 1 -Weighted Magnetic Resonance Imaging

Gadolinium-Incorporated Carbon Nanodots for T1-Weighted Magnetic Resonance Imaging

A novel manganese chelated macromolecular MRI contrast agent based on O-carboxymethyl chitosan derivatives.

A Biocompatible Gadolinium-Based Amino Acid Copolymer Contrast Agent for Magnetic Resonance Imaging

Crosslinked and Biodegradable Polymeric System as Safe Magnetic Resonance Imaging Contrast Agent.

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

Nanoassemblies with Gd-chelating lipids (GMO@DTPA-BSA-Gd) as a potential new type of high molecular weight contrast agents

Kilogram-Scale Synthesis of Extremely Small Gadolinium Oxide Nanoparticles As a T1-Weighted Contrast Agent for Magnetic Resonance Imaging

An MRI contrast agent based on a zwitterionic metal-chelating polymer for hepatorenal angiography and tumor imaging.